{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:03:52Z","timestamp":1777057432455,"version":"3.51.4"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus\u00a0is a highly contagious microorganism, and despite substantial investigation, no progress has been achieved in treating post-COVID complications. However, the virus has made various mutations and has spread around the world. Researchers have tried different treatments to reduce the side effects of the COVID-19 symptoms. One of the most common and effective treatments now used is steroid therapy to reduce the complications of this disease. Long-term steroid therapy for chronic inflammation following COVID-19 is harmful and increases the risk of secondary infection, and effective treatment remains challenging owing to fibrosis and severe inflammation and infection. Sometimes our immune system can severely damage ourselves in disease. In the past, many researchers have conducted various studies on the immunomodulatory properties of stem cells. This property of stem cells led them to modulate the immune system of autoimmune diseases like diabetes, multiple sclerosis, and Parkinson's. Because of their immunomodulatory properties, stem cell-based therapy employing mesenchymal or hematopoietic stem cells may be a viable alternative treatment option in some patients. By priming the immune system and providing cytokines, chemokines, and growth factors, stem cells can be employed to build a long-term regenerative and protective response. This review addresses the latest trends and rapid progress in stem cell treatment for Acute Respiratory Distress Syndrome (ARDS) following COVID-19.<\/jats:p>","DOI":"10.1186\/s43556-021-00067-8","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T03:02:33Z","timestamp":1645066953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Stem cell therapy for COVID-19 pneumonia"],"prefix":"10.1186","volume":"3","author":[{"given":"Maziar Malekzadeh","family":"Kebria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiman Brouki","family":"Milan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noshad","family":"Peyravian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheil","family":"Khatibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0232-352X","authenticated-orcid":false,"given":"Masoud","family":"Mozafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"67_CR1","doi-asserted-by":"publisher","unstructured":"Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020:200490. https:\/\/doi.org\/10.1148\/radiol.2020200490.","DOI":"10.1148\/radiol.2020200490"},{"key":"67_CR2","doi-asserted-by":"publisher","unstructured":"Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;102433. https:\/\/doi.org\/10.1016\/j.jaut.2020.102433.","DOI":"10.1016\/j.jaut.2020.102433"},{"issue":"6","key":"67_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/jmv.25740","volume":"92","author":"Q Lu","year":"2020","unstructured":"Lu Q, Shi Y. Coronavirus disease (COVID-19) and neonate: what neonatologist need to know. J Med Virol. 2020;92(6):564\u20137. https:\/\/doi.org\/10.1002\/jmv.25740.","journal-title":"J Med Virol"},{"issue":"5","key":"67_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jiph.2020.03.019","volume":"13","author":"H Harapan","year":"2020","unstructured":"Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5):667\u201373. https:\/\/doi.org\/10.1016\/j.jiph.2020.03.019.","journal-title":"J Infect Public Health"},{"key":"67_CR5","doi-asserted-by":"publisher","unstructured":"Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang. China J Infect. 2020;02(016). https:\/\/doi.org\/10.1016\/j.jinf.","DOI":"10.1016\/j.jinf"},{"issue":"9","key":"67_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/M20-0504","volume":"172","author":"SA Lauer","year":"2020","unstructured":"Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577\u201382. https:\/\/doi.org\/10.7326\/M20-0504.","journal-title":"Ann Intern Med"},{"key":"67_CR7","doi-asserted-by":"publisher","unstructured":"Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 2020;2012410.https:\/\/doi.org\/10.1056\/NEJMoa2012410","DOI":"10.1056\/NEJMoa2012410"},{"issue":"6","key":"67_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/10408363.2020.1783198","volume":"57","author":"M Ciotti","year":"2020","unstructured":"Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020;57(6):365\u201388. https:\/\/doi.org\/10.1080\/10408363.2020.1783198.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"67_CR9","doi-asserted-by":"publisher","unstructured":"Golchin A, Seyedjafari E, Ardeshirylajimi A. Mesenchymal stem cell therapy for COVID-19: present or future. Stem Cell Rev Rep. 2020;1-7. https:\/\/doi.org\/10.1007\/s12015-020-09973.","DOI":"10.1007\/s12015-020-09973"},{"issue":"1","key":"67_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01804-6","volume":"11","author":"K Xiao","year":"2020","unstructured":"Xiao K, Hou F, Huang X, Li B, Qian ZR, Xie L. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19. Stem Cell Res Ther. 2020;11(1):1\u20137. https:\/\/doi.org\/10.1186\/s13287-020-01804-6.","journal-title":"Stem Cell Res Ther"},{"key":"67_CR11","doi-asserted-by":"publisher","unstructured":"Carlson RH. Mesenchymal stem cells modulate immune system in GvHD patients. Oncology. Times. 2006;22. https:\/\/doi.org\/10.1097\/01.COT.0000316085.03570.ce.","DOI":"10.1097\/01.COT.0000316085.03570.ce"},{"key":"67_CR12","doi-asserted-by":"publisher","unstructured":"Can A, Coskun H. The rationale of using mesenchymal stem cells in patients with COVID-19 related acute respiratory distress syndrome: what to expect. Stem Cells Transl Med. 2020:20\u20130164. https:\/\/doi.org\/10.1002\/sctm.20-0164.","DOI":"10.1002\/sctm.20-0164"},{"key":"67_CR13","doi-asserted-by":"publisher","unstructured":"Yufang S, Wang Y, Changshun S, Jianan H, Jianhe G, Xiaoping H, et al. (COVID-19) infection: the perspectives on immune responses. Cell Death Differ. 2020:s41418\u2013020\u20130530-3. https:\/\/doi.org\/10.1038\/s41418-020-0530-3.","DOI":"10.1038\/s41418-020-0530-3"},{"issue":"7821","key":"67_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients. Nature. 2020;584(7821):430. https:\/\/doi.org\/10.1038\/s41586-020-2521-4.","journal-title":"Nature."},{"key":"67_CR15","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3389\/fimmu.2020.01563","volume":"11","author":"F Saldanha-Araujo","year":"2020","unstructured":"Saldanha-Araujo F, Melga\u00e7o Garcez E, Silva-Carvalho AE, Carvalho JL. Mesenchymal stem cells: a new piece in the puzzle of COVID-19 treatment. Front Immunol. 2020;11:1563. https:\/\/doi.org\/10.3389\/fimmu.2020.01563.","journal-title":"Front Immunol"},{"key":"67_CR16","doi-asserted-by":"publisher","unstructured":"Gupta A, Kashte S, Gupta M, Rodriguez HC, Gautam SS, Kadam S. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective. Hum Cell. 2020;1-12. https:\/\/doi.org\/10.1007\/s13577-020-00407-w.","DOI":"10.1007\/s13577-020-00407-w"},{"issue":"14","key":"67_CR17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1089\/scd.2020.0089","volume":"29","author":"SK Lim","year":"2020","unstructured":"Lim SK, Giebel B, Weiss DJ, Witwer KW, Rohde E, et al. Re: \"Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19\" by Sengupta. Stem Cells Dev. 2020;29(14):877\u20138. https:\/\/doi.org\/10.1089\/scd.2020.0089.","journal-title":"Stem Cells Dev"},{"key":"67_CR18","doi-asserted-by":"publisher","unstructured":"Li H, Liu S-M, Yu X-H, Tang S-L, Tang C-K. Coronavirus disease 2019 [COVID-19]: current status and future perspective. Int J Antimicrob Agents. 2020:105951. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105951.","DOI":"10.1016\/j.ijantimicag.2020.105951"},{"key":"67_CR19","doi-asserted-by":"publisher","unstructured":"Tyrrell D, Bynoe M. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966:76\u20137. https:\/\/doi.org\/10.1016\/s0140-6736(66)92364-6.","DOI":"10.1016\/s0140-6736(66)92364-6"},{"issue":"3","key":"67_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/tmi.13383","volume":"25","author":"TP Velavan","year":"2020","unstructured":"Velavan TP, Meyer CG. The COVID-19 epidemic. Tropical Med Int Health. 2020;25(3):278. https:\/\/doi.org\/10.1111\/tmi.13383.","journal-title":"Tropical Med Int Health"},{"key":"67_CR21","doi-asserted-by":"publisher","unstructured":"Tu H, Tu S, Gao S, Shao A, Sheng J. The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event. J Inf Secur. 2020;1588076901. https:\/\/doi.org\/10.1016\/j.jinf.2020.04.011.","DOI":"10.1016\/j.jinf.2020.04.011"},{"key":"67_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbi.2020.04.040","volume":"87","author":"MJ Butler","year":"2020","unstructured":"Butler MJ, Barrientos RM. The impact of nutrition on COVID-19 susceptibility and long-term consequences. Brain Behav Immun. 2020;87:53\u20134. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.040.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"67_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41467-017-00525-4","volume":"8","author":"A Rana","year":"2017","unstructured":"Rana A, Oliveira MP, Khamoui AV, Aparicio R, Rera M, Rossiter HB, et al. Promoting drp1-mediated mitochondrial fission in midlife prolongs healthy lifespan of drosophila melanogaster. Nat Commun. 2017;8(1):448. https:\/\/doi.org\/10.1038\/s41467-017-00525-4.","journal-title":"Nat Commun"},{"issue":"14","key":"67_CR24","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jama.2020.4344","volume":"323","author":"E Livingston","year":"2020","unstructured":"Livingston E, Bucher K. Coronavirus disease 2019 [COVID-19] in Italy. Jama. 2020;323(14):1335. https:\/\/doi.org\/10.1001\/jama.2020.4344.","journal-title":"Jama."},{"issue":"4","key":"67_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jinf.2020.02.018","volume":"80","author":"S Tian","year":"2020","unstructured":"Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. J Inf Secur. 2020;80(4):401\u20136. https:\/\/doi.org\/10.1016\/j.jinf.2020.02.018.","journal-title":"J Inf Secur"},{"issue":"2","key":"67_CR26","doi-asserted-by":"publisher","first-page":"E46","DOI":"10.1148\/radiol.2020200823","volume":"296","author":"HX Bai","year":"2020","unstructured":"Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020;296(2):E46\u201354. https:\/\/doi.org\/10.1148\/radiol.2020200823.","journal-title":"Radiology."},{"issue":"25","key":"67_CR27","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMra032498","volume":"349","author":"JS Peiris","year":"2003","unstructured":"Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med. 2003;349(25):2431\u201341. https:\/\/doi.org\/10.1056\/NEJMra032498.","journal-title":"N Engl J Med"},{"key":"67_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbi.2020.04.077","volume":"87","author":"A Avula","year":"2020","unstructured":"Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020;87:115\u20139. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.077.","journal-title":"Brain Behav Immun"},{"key":"67_CR29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.55570","volume":"9","author":"K Gostic","year":"2020","unstructured":"Gostic K, Gomez AC, Mummah RO, Kucharski AJ, Lloyd-Smith JO. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife. 2020;9:e55570. https:\/\/doi.org\/10.7554\/eLife.55570.","journal-title":"Elife."},{"key":"67_CR30","doi-asserted-by":"publisher","unstructured":"Cristina M, Valdes Ana M, Freidin Maxim B, Carole S, Nguyen H, Long H. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020:04.05.20048421v1. https:\/\/doi.org\/10.1038\/s41591-020-0916-2.","DOI":"10.1038\/s41591-020-0916-2"},{"issue":"24","key":"67_CR31","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMc2010419","volume":"382","author":"P Goyal","year":"2020","unstructured":"Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York city. N Engl J Med. 2020;382(24):2372\u20134. https:\/\/doi.org\/10.1056\/NEJMc2010419.","journal-title":"N Engl J Med"},{"issue":"6","key":"67_CR32","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/gutjnl-2020-320891","volume":"69","author":"Y Song","year":"2020","unstructured":"Song Y, Liu P, Shi X, Chu Y, Zhang J, Xia J, et al. SARS-COV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020;69(6):1143\u20134. https:\/\/doi.org\/10.1136\/gutjnl-2020-320891.","journal-title":"Gut."},{"issue":"3","key":"67_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1164\/rccm.202006-2157CP","volume":"202","author":"MJ Tobin","year":"2020","unstructured":"Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med. 2020;202(3):356\u201360. https:\/\/doi.org\/10.1164\/rccm.202006-2157CP.","journal-title":"Am J Respir Crit Care Med"},{"issue":"SI-1","key":"67_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3906\/sag-2004-172","volume":"50","author":"C Bulut","year":"2020","unstructured":"Bulut C, Kato Y. Epidemiology of COVID-19. Turkish J Med Sci. 2020;50(SI-1):563\u201370. https:\/\/doi.org\/10.3906\/sag-2004-172.","journal-title":"Turkish J Med Sci"},{"issue":"SI-1","key":"67_CR35","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3906\/sag-2004-168","volume":"50","author":"A Tufan","year":"2020","unstructured":"Tufan A, G\u00dcLER AA, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turkish J Med Sci. 2020;50(SI-1):620\u201332. https:\/\/doi.org\/10.3906\/sag-2004-168.","journal-title":"Turkish J Med Sci"},{"issue":"7","key":"67_CR36","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.3390\/ijms21072272","volume":"21","author":"S Jawhara","year":"2020","unstructured":"Jawhara S. Could Intravenous immunoglobulin collected from recovered coronavirus patients protect against COVID-19 and strengthen the immune system of new patients? Int J Mol Sci. 2020;21(7):2272. https:\/\/doi.org\/10.3390\/ijms21072272.","journal-title":"Int J Mol Sci"},{"issue":"10229","key":"67_CR37","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0.","journal-title":"Lancet"},{"key":"67_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2020.102100","volume":"50","author":"R Tandon","year":"2020","unstructured":"Tandon R. The COVID-19 pandemic, personal reflections on editorial responsibility. Asian J Psychiatr. 2020;50:102100. https:\/\/doi.org\/10.1016\/j.ajp.2020.102100.","journal-title":"Asian J Psychiatr"},{"issue":"1","key":"67_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cels.2020.06.008","volume":"11","author":"KE Wu","year":"2020","unstructured":"Wu KE, Fazal FM, Parker KR, Zou J, Chang HY. Rna-gps predicts SARS-COV-2 rna residency to host mitochondria and nucleolus. Cell Syst. 2020;11(1):102\u20138 e103. https:\/\/doi.org\/10.1016\/j.cels.2020.06.008.","journal-title":"Cell Syst"},{"issue":"2","key":"67_CR40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/tropicalmed5020080","volume":"5","author":"T Oyelade","year":"2020","unstructured":"Oyelade T, Alqahtani J, Canciani G. Prognosis of COVID-19 in patients with liver and kidney diseases: an early systematic review and meta-analysis. Trop Med Infect Dis. 2020;5(2):80. https:\/\/doi.org\/10.3390\/tropicalmed5020080.","journal-title":"Trop Med Infect Dis"},{"key":"67_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-020-00427-x","volume":"10","author":"J Cai","year":"2020","unstructured":"Cai J, Wu J, Wang J, Li Y, Hu X, Luo S, et al. Extracellular vesicles derived from different sources of mesenchymal stem cells: therapeutic effects and translational potential. Cell Biosci. 2020;10:1\u20134. 10:1-14. https:\/\/doi.org\/10.1186\/s13578-020-00427-x.","journal-title":"Cell Biosci"},{"issue":"1","key":"67_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/jcmm.14788.10.1111\/jcmm.14788","volume":"24","author":"C Hu","year":"2020","unstructured":"Hu C, Wu Z, Li L. Pre treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases. J Cell Mol Med. 2020;24(1):40\u20139. https:\/\/doi.org\/10.1111\/jcmm.14788.10.1111\/jcmm.14788.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"67_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1681\/ASN.2019050545","volume":"31","author":"J Xu","year":"2020","unstructured":"Xu J, Chen J, Li W, Lian W, Huang J, Lai B, et al. Additive therapeutic effects of mesenchymal stem cells and IL-37 for systemic lupus erythematosus. J Am Soc Nephrol. 2020;31(1):54\u201365. https:\/\/doi.org\/10.1681\/ASN.2019050545.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"67_CR44","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","volume":"25","author":"G Chamberlain","year":"2007","unstructured":"Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25(11):2739\u201349. https:\/\/doi.org\/10.1634\/stemcells.2007-0197.","journal-title":"Stem Cells"},{"issue":"2","key":"67_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5966\/sctm.2011-0018","volume":"1","author":"S Maxson","year":"2012","unstructured":"Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, LeRoux MA. Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med. 2012;1(2):142\u20139. https:\/\/doi.org\/10.5966\/sctm.2011-0018.","journal-title":"Stem Cells Transl Med"},{"issue":"7","key":"67_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-02788-0","volume":"11","author":"R Yang","year":"2020","unstructured":"Yang R, Huang H, Cui S, Zhou Y, Zhang T, Zhou Y. IFN-\u03b3 promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b. Cell Death Dis. 2020;11(7):1\u201312. https:\/\/doi.org\/10.1038\/s41419-020-02788-0.","journal-title":"Cell Death Dis"},{"key":"67_CR47","doi-asserted-by":"publisher","unstructured":"Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K. Challenges and controversies in human mesenchymal stem cell therapy. Stem Cells Int. 2019;9628536. https:\/\/doi.org\/10.1155\/2019\/9628536.","DOI":"10.1155\/2019\/9628536"},{"issue":"3","key":"67_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.14336\/AD.2020.0403","volume":"11","author":"S \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk S, El\u00e7in AE, El\u00e7in YM. Mesenchymal stem cells for coronavirus [COVID-19]-induced pneumonia: revisiting the paracrine hypothesis with new hopes? Aging Dis. 2020;11(3):477. https:\/\/doi.org\/10.14336\/AD.2020.0403.","journal-title":"Aging Dis"},{"issue":"5","key":"67_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-020-1034-8","volume":"22","author":"S Suvakov","year":"2020","unstructured":"Suvakov S, Richards C, Nikolic V, Simic T, McGrath K, Krasnodembskaya A, et al. Emerging therapeutic potential of mesenchymal stem\/stromal cells in preeclampsia. Curr Hypertens Rep. 2020;22(5):1\u201313. https:\/\/doi.org\/10.1007\/s11906-020-1034-8.","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"67_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01668-w","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Cui J, Wang H, Hezam K, Zhao X, Huang H, et al. Enhanced therapeutic effects of MSC-derived extracellular vesicles with an injectable collagen matrix for experimental acute kidney injury treatment. Stem Cell Res Ther. 2020;11(1):1\u201312. https:\/\/doi.org\/10.1186\/s13287-020-01668-w.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"67_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0802-8","volume":"9","author":"LH Silva","year":"2018","unstructured":"Silva LH, Antunes MA, Dos Santos CC, Weiss DJ, Cruz FF, Rocco PR. Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases. Stem Cell Res Ther. 2018;9(1):1\u20139. https:\/\/doi.org\/10.1186\/s13287-018-0802-8.","journal-title":"Stem Cell Res Ther"},{"key":"67_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biomaterials.2018.04.055","volume":"174","author":"A Bier","year":"2018","unstructured":"Bier A, Berenstein P, Kronfeld N, Morgoulis D, Ziv-Av A, Goldstein H, et al. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy. Biomaterials. 2018;174:67\u201378. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.04.055.","journal-title":"Biomaterials"},{"issue":"6","key":"67_CR53","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/1535370220910690","volume":"245","author":"X Ma","year":"2020","unstructured":"Ma X, Liu J, Yang X, Fang K, Zheng P, Liang X, et al. Mesenchymal stem cells maintain the stemness of colon cancer stem cells via interleukin-8\/mitogen-activated protein kinase signaling pathway. Exp Biol Med. 2020;245(6):562\u201375. https:\/\/doi.org\/10.1177\/1535370220910690.","journal-title":"Exp Biol Med"},{"key":"67_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fbioe.2020.00043","volume":"8","author":"A Hmadcha","year":"2020","unstructured":"Hmadcha A, Martin-Montalvo A, Gauthier BR, Soria B, Capilla-Gonzalez V. Therapeutic potential of mesenchymal stem cells for Cancer therapy. Front Bioeng Biotechnol. 2020;8:43. https:\/\/doi.org\/10.3389\/fbioe.2020.00043.","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"67_CR55","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/stem.2564","volume":"35","author":"Y Song","year":"2017","unstructured":"Song Y, Dou H, Li X, Zhao X, Li Y, Liu D, et al. Exosomal miR 146a contributes to the enhanced therapeutic efficacy of interleukin1\u03b2 primed mesenchymal stem cells against sepsis. Stem Cells. 2017;35(5):1208\u201321. https:\/\/doi.org\/10.1002\/stem.2564.","journal-title":"Stem Cells"},{"issue":"1","key":"67_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0766-0","volume":"9","author":"Z Xie","year":"2018","unstructured":"Xie Z, Ye G, Wang P, Li J, Liu W, Li M, et al. Interleukin-6\/interleukin-6 receptor complex promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells. Stem Cell Res Ther. 2018;9(1):1\u201310. https:\/\/doi.org\/10.1186\/s13287-017-0766-0.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"67_CR57","doi-asserted-by":"publisher","first-page":"E194","DOI":"10.1111\/hepr.12969","volume":"48","author":"J Wang","year":"2018","unstructured":"Wang J, Ren H, Yuan X, Ma H, Shi X, Ding Y. Interleukin10 secreted by mesenchymal stem cells attenuates acute liver failure through inhibiting pyroptosis. Hepatol Res. 2018;48(3):E194\u2013202. https:\/\/doi.org\/10.1111\/hepr.12969.","journal-title":"Hepatol Res"},{"key":"67_CR58","doi-asserted-by":"publisher","unstructured":"Thanunchai M, Hongeng S, Thitithanyanont A. Mesenchymal stromal cells and viral infection. Stem Cells Int. 2015;860950. https:\/\/doi.org\/10.1155\/2015\/860950.","DOI":"10.1155\/2015\/860950"},{"issue":"1","key":"67_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0499-0","volume":"8","author":"W-X Gao","year":"2017","unstructured":"Gao W-X, Sun Y-Q, Shi J, Li C-L, Fang S-B, Wang D, et al. Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells. Stem Cell Res Ther. 2017;8(1):1\u201316. https:\/\/doi.org\/10.1186\/s13287-017-0499-0.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"67_CR60","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/stem.3010","volume":"37","author":"B Romano","year":"2019","unstructured":"Romano B, Elangovan S, Erreni M, Sala E, Petti L, Kunderfranco P, et al. TNF stimulated gene is a key regulator in switching stemness and biological properties of mesenchymal stem cells. Stem Cells. 2019;37(7):973\u201387. https:\/\/doi.org\/10.1002\/stem.3010.","journal-title":"Stem Cells"},{"key":"67_CR61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.rvsc.2018.05.011","volume":"119","author":"H-M Yang","year":"2018","unstructured":"Yang H-M, Song W-J, Li Q, Kim S-Y, Kim H-J, Ryu M-O, et al. Canine mesenchymal stem cells treated with TNF-\u03b1 and IFN-\u03b3 enhance anti-inflammatory effects through the COX-2\/PGE2 pathway. Res Vet Sci. 2018;119:19\u201326. https:\/\/doi.org\/10.1016\/j.rvsc.2018.05.011.","journal-title":"Res Vet Sci"},{"key":"67_CR62","doi-asserted-by":"publisher","unstructured":"Wang X, Liang T, Qiu J, Qiu X, Gao B, Gao W, et al. Melatonin reverses the loss of stemness induced by TNF-\u03b1 in human bone marrow mesenchymal stem cells through upregulation of YAP expression. Stem Cells Int. 2019;6568394. https:\/\/doi.org\/10.1155\/2019\/6568394.","DOI":"10.1155\/2019\/6568394"},{"key":"67_CR63","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cellimm.2017.11.010","volume":"326","author":"K Qi","year":"2018","unstructured":"Qi K, Li N, Zhang Z, Melino G. Tissue regeneration: the crosstalk between mesenchymal stem cells and immune response. Cell Immunol. 2018;326:86\u201393. https:\/\/doi.org\/10.1016\/j.cellimm.2017.11.010.","journal-title":"Cell Immunol"},{"issue":"1","key":"67_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-019-02167-0","volume":"17","author":"C Hu","year":"2019","unstructured":"Hu C, Li L. The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation. J Transl Med. 2019;17(1):1\u201312. https:\/\/doi.org\/10.1186\/s12967-019-02167-0.","journal-title":"J Transl Med"},{"issue":"7","key":"67_CR65","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.drudis.2020.04.022","volume":"25","author":"L O'Driscoll","year":"2020","unstructured":"O'Driscoll L. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment. Drug Discov Today. 2020;25(7):1124. https:\/\/doi.org\/10.1016\/j.drudis.2020.04.022.","journal-title":"Drug Discov Today"},{"issue":"8","key":"67_CR66","doi-asserted-by":"publisher","first-page":"400","DOI":"10.5483\/BMBRep.2020.53.8.121","volume":"53","author":"K Jayaramayya","year":"2020","unstructured":"Jayaramayya K, Mahalaxmi I, Subramaniam MD, Raj N, Dayem AA, Lim KM, et al. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatmen. BMB Rep. 2020;53(8):400. https:\/\/doi.org\/10.5483\/BMBRep.2020.53.8.121.","journal-title":"BMB Rep"},{"issue":"10","key":"67_CR67","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/cas.13334","volume":"108","author":"HY Lee","year":"2017","unstructured":"Lee HY, Hong IS. Double-edged sword of mesenchymal stem cells: cancerpromoting versus therapeutic potential. Cancer Sci. 2017;108(10):1939\u201346. https:\/\/doi.org\/10.1111\/cas.13334.","journal-title":"Cancer Sci"},{"key":"67_CR68","doi-asserted-by":"publisher","unstructured":"Li H, Shen S, Fu H, Wang Z, Li X, Sui X, et al. Immunomodulatory functions of mesenchymal stem cells in tissue engineering. Stem Cells Int. 2019;9671206. https:\/\/doi.org\/10.1155\/2019\/9671206.","DOI":"10.1155\/2019\/9671206"},{"key":"67_CR69","doi-asserted-by":"publisher","unstructured":"Wang M, Yuan Q, Xie L. Mesenchymal stem cell-based immunomodulation: properties and clinical application. Stem Cells Int. 2018;3057624. https:\/\/doi.org\/10.1155\/2018\/3057624.","DOI":"10.1155\/2018\/3057624"},{"key":"67_CR70","doi-asserted-by":"publisher","unstructured":"Heo JS, Choi Y, Kim HO. Adipose-derived mesenchymal stem cells promote M2 macrophage phenotype through exosomes. Stem Cells Int. 2019;7921760. https:\/\/doi.org\/10.1155\/2019\/7921760.","DOI":"10.1155\/2019\/7921760"},{"issue":"1","key":"67_CR71","doi-asserted-by":"publisher","first-page":"e12712","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53(1):e12712. https:\/\/doi.org\/10.1111\/cpr.12712.","journal-title":"Cell Prolif"},{"issue":"12","key":"67_CR72","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41423-019-0204-6","volume":"16","author":"Y Li","year":"2019","unstructured":"Li Y, Zhang D, Xu L, Dong L, Zheng J, Lin Y, et al. Cell\u2013cell contact with pro-inflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models. Cell Mol Immunol. 2019;16(12):908\u201320. https:\/\/doi.org\/10.1038\/s41423-019-0204-6.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"67_CR73","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/bjd.15078","volume":"176","author":"M Orciani","year":"2017","unstructured":"Orciani M, Campanati A, Caffarini M, Ganzetti G, Consales V, Lucarini G, et al. T helper [Th] 1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem. Br J Dermatol. 2017;176(6):1569\u201376. https:\/\/doi.org\/10.1111\/bjd.15078.","journal-title":"Br J Dermatol"},{"issue":"2","key":"67_CR74","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/cells10020280","volume":"10","author":"E Kuca-Warnawin","year":"2021","unstructured":"Kuca-Warnawin E, Janicka I, Bonek K, Kontny E. Modulatory impact of adipose-derived mesenchymal stem cells of ankylosing spondylitis patients on T helper cell differentiation. Cells. 2021;10(2):280. https:\/\/doi.org\/10.3390\/cells10020280.","journal-title":"Cells."},{"issue":"8","key":"67_CR75","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1136\/jim-2020-001559","volume":"68","author":"DS Dahiya","year":"2020","unstructured":"Dahiya DS, Kichloo A, Albosta M, Pagad S, Wani F. Gastrointestinal implications in covid-19. J Investig Med. 2020;68(8):1397\u2013401. https:\/\/doi.org\/10.1136\/jim-2020-001559.","journal-title":"J Investig Med"},{"key":"67_CR76","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fimmu.2020.00233","volume":"11","author":"L Geng","year":"2020","unstructured":"Geng L, Tang X, Wang S, Sun Y, Wang D, Tsao BP, et al. Reduced let-7f in bone marrow-derived mesenchymal stem cells triggers Treg\/Th17 imbalance in patients with systemic lupus erythematosus. Front Immunol. 2020;11:233. https:\/\/doi.org\/10.3389\/fimmu.2020.00233.","journal-title":"Front Immunol"},{"issue":"1","key":"67_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-14979-5","volume":"7","author":"W Zhang","year":"2017","unstructured":"Zhang W, Zhou L, Dang J, Zhang X, Wang J, Chen Y, et al. Human gingiva-derived mesenchymal stem cells ameliorate streptozoticin-induced T1DM in mice via suppression of T effector cells and up-regulating Treg subsets. Sci Rep. 2017;7(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-017-14979-5.","journal-title":"Sci Rep"},{"key":"67_CR78","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3389\/fbioe.2020.00554","volume":"8","author":"W Chrzanowski","year":"2020","unstructured":"Chrzanowski W, Kim SY, McClements L. Can stem cells beat COVID-19: advancing stem cells and extracellular vesicles toward mainstream medicine for lung injuries associated with SARS-COV-2 infections. Front Bioeng Biotechnol. 2020;8:554. https:\/\/doi.org\/10.3389\/fbioe.2020.00554.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"67_CR79","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-016-0276-z","volume":"9","author":"K Zhao","year":"2016","unstructured":"Zhao K, Liu Q. The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation. J Hematol Oncol. 2016;9(1):46. https:\/\/doi.org\/10.1186\/s13045-016-0276-z.","journal-title":"J Hematol Oncol"},{"key":"67_CR80","doi-asserted-by":"publisher","unstructured":"Rizvanov AA, Persson J, \u015eahin F, Bellusci S, Oliveira PJ. Hematopoietic and mesenchymal stem cells in biomedical and clinical applications. 2016;3157365. https:\/\/doi.org\/10.1155\/2016\/3157365.","DOI":"10.1155\/2016\/3157365"},{"issue":"1","key":"67_CR81","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/cells8010047","volume":"8","author":"G Ottaviano","year":"2019","unstructured":"Ottaviano G, Chiesa R, Feuchtinger T, Vickers MA, Dickinson A, Gennery AR, et al. Adoptive T cell therapy strategies for viral infections in patients receiving haematopoietic stem cell transplantation. Cells. 2019;8(1):47. https:\/\/doi.org\/10.3390\/cells8010047.","journal-title":"Cells."},{"issue":"2","key":"67_CR82","doi-asserted-by":"publisher","first-page":"e0228451","DOI":"10.1371\/journal.pone.0228451","volume":"15","author":"F D\u00fcver","year":"2020","unstructured":"D\u00fcver F, Wei\u00dfbrich B, Eyrich M, W\u00f6lfl M, Schlegel PG, Wiegering V. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients\u2013a single center 11-year analysis. PLoS One. 2020;15(2):e0228451. https:\/\/doi.org\/10.1371\/journal.pone.0228451.","journal-title":"PLoS One"},{"key":"67_CR83","doi-asserted-by":"publisher","unstructured":"Liang B, Li T, Wu H, Yang W, Li Y, Li J, et al. Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells. 2020;99(31). https:\/\/doi.org\/10.1097\/MD.0000000000021429.","DOI":"10.1097\/MD.0000000000021429"},{"key":"67_CR84","doi-asserted-by":"publisher","unstructured":"Metcalfe SM. Mesenchymal stem cells and management of COVID-19 pneumonia. Med Drug Discovery. 2020;100019. https:\/\/doi.org\/10.1016\/j.medidd.2020.100019.","DOI":"10.1016\/j.medidd.2020.100019"},{"issue":"1","key":"67_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jre.12684","volume":"55","author":"S Novello","year":"2020","unstructured":"Novello S, Debouche A, Philippe M, Naudet F, Jeanne S. Clinical application of mesenchymal stem cells in periodontal regeneration: a systematic review and meta analysis. J Periodontal Res. 2020;55(1):1\u201312. https:\/\/doi.org\/10.1111\/jre.12684.","journal-title":"J Periodontal Res"},{"issue":"4","key":"67_CR86","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10238-020-00648-x","volume":"20","author":"M Gavriatopoulou","year":"2020","unstructured":"Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, et al. Organ-specific manifestations of covid-19 infection. Clin Exp Med. 2020;20(4):493\u2013506. https:\/\/doi.org\/10.1007\/s10238-020-00648-x.","journal-title":"Clin Exp Med"},{"issue":"13","key":"67_CR87","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1001\/jama.2020.2467","volume":"323","author":"JE Wong","year":"2020","unstructured":"Wong JE, Leo YS, Tan CC. COVID-19 in Singapore\u2014current experience: critical global issues that require attention and action. Jama. 2020;323(13):1243\u20134. https:\/\/doi.org\/10.1001\/jama.2020.2467.","journal-title":"Jama."},{"issue":"5","key":"67_CR88","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1097\/TA.0b013e318283d942","volume":"74","author":"F Zhu","year":"2013","unstructured":"Zhu F, Xia Z-F. Paracrine activity of stem cells in therapy for acute lung injury and adult respiratory distress syndrome. J Trauma Acute Care Surg. 2013;74(5):1351\u20136. https:\/\/doi.org\/10.1097\/TA.0b013e318283d942.","journal-title":"J Trauma Acute Care Surg"},{"key":"67_CR89","doi-asserted-by":"publisher","unstructured":"Serikov VB, Krasnodembskaya A, Lee JW, Eldridge MW, Matthay MA. MSCs for treatment of acute lung injury. Mesenchymal Stromal Cells: Springer; 2013; p. 561\u201370. https:\/\/doi.org\/10.1007\/978-1-4614-5711-4.","DOI":"10.1007\/978-1-4614-5711-4"},{"key":"67_CR90","doi-asserted-by":"publisher","unstructured":"Du J, Li H, Lian J, Zhu X, Qiao L, Lin J. Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury. Stem Cell Res Ther 2020;11[1]:1\u20139. https:\/\/doi.org\/10.1186\/s13287-020-01699-3.","DOI":"10.1186\/s13287-020-01699-3"},{"key":"67_CR91","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3389\/fimmu.2020.01091","volume":"11","author":"M Guido","year":"2020","unstructured":"Guido M, Norman D, Julian K-M, Sven G, Hans-Dieter V, Petra R. MSC therapies for COVID-19: importance of patient coagulopathy, Thromboprophylaxis, cell product quality and mode of delivery for treatment safety and efficacy. Front Immunol. 2020;11:1091. https:\/\/doi.org\/10.3389\/fimmu.2020.01091.","journal-title":"Front Immunol"},{"issue":"10","key":"67_CR92","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.eng.2020.02.006","volume":"6","author":"J Chen","year":"2020","unstructured":"Chen J, Hu C, Chen L, Tang L, Zhu Y, Xu X. Clinical study of mesenchymal stem cell treatment for acute respiratory distress syndrome induced by epidemic influenza a [H7N9] infection: a hint for COVID-19 treatment. Engineering. 2020;6(10):1153\u201361. https:\/\/doi.org\/10.1016\/j.eng.2020.02.006.","journal-title":"Engineering."},{"key":"67_CR93","doi-asserted-by":"publisher","unstructured":"Khoury M, Cuenca J, Cruz FF, Figueroa FE, Rocco PR, Weiss DJ. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19. Eur Respir J. 2020;55(6). https:\/\/doi.org\/10.1183\/13993003.00858-2020.","DOI":"10.1183\/13993003.00858-2020"},{"issue":"12","key":"67_CR94","doi-asserted-by":"publisher","first-page":"e2995","DOI":"10.1002\/jgm.2995","volume":"19","author":"AES Shafei","year":"2017","unstructured":"Shafei AES, Ali MA, Ghanem HG, Shehata AI, Abdelgawad AA, Handal HR, et al. Mesenchymal stem cell therapy: a promising cell based therapy for treatment of myocardial infarction. The. J Gene Med. 2017;19(12):e2995. https:\/\/doi.org\/10.1002\/jgm.2995.","journal-title":"J Gene Med"},{"issue":"1","key":"67_CR95","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s13287-019-1518-0","volume":"10","author":"J Han","year":"2019","unstructured":"Han J, Liu Y, Liu H, Li Y. Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome. Stem Cell Res Ther. 2019;10(1):386. https:\/\/doi.org\/10.1186\/s13287-019-1518-0.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"67_CR96","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/sctm.20-0146","volume":"9","author":"W Qu","year":"2020","unstructured":"Qu W, Wang Z, Hare JM, Bu G, Mallea JM, Pascual JM, et al. Cell based therapy to reduce mortality from COVID-19: systematic review and meta analysis of human studies on acute respiratory distress syndrome. Stem Cells Transl Med. 2020;9(9):1007\u201322. https:\/\/doi.org\/10.1002\/sctm.20-0146.","journal-title":"Stem Cells Transl Med"},{"key":"67_CR97","doi-asserted-by":"publisher","unstructured":"Zhao RC. Stem Cell\u2013Based Therapy for Coronavirus Disease 2019. Stem Cells Dev. 2020. https:\/\/doi.org\/10.1089\/scd.2020.0071.","DOI":"10.1089\/scd.2020.0071"},{"issue":"8","key":"67_CR98","doi-asserted-by":"publisher","first-page":"e1008735","DOI":"10.1371\/journal.ppat.1008735","volume":"16","author":"D Montelongo-Jauregui","year":"2020","unstructured":"Montelongo-Jauregui D, Vila T, Sultan AS, Jabra-Rizk MA. Convalescent serum therapy for COVID-19: a 19th century remedy for a 21st century disease. PLoS Pathog. 2020;16(8):e1008735. https:\/\/doi.org\/10.1371\/journal.ppat.1008735.","journal-title":"PLoS Pathog"},{"issue":"6518","key":"67_CR99","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"JL Daly","year":"2020","unstructured":"Daly JL, Simonetti B, Klein K, Chen KE, Williamson MK, Anton-Plagaro C, et al. Neuropilin-1 is a host factor for SARS-COV-2 infection. Science. 2020;370(6518):861\u20135. https:\/\/doi.org\/10.1126\/science.abd3072.","journal-title":"Science."},{"issue":"02","key":"67_CR100","doi-asserted-by":"publisher","first-page":"086","DOI":"10.1055\/s-0040-1718584","volume":"110","author":"B Jethani","year":"2021","unstructured":"Jethani B, Gupta M, Wadhwani P, Thomas R, Balakrishnan T, Mathew G, et al. Clinical characteristics and remedy profiles of patients with COVID-19: a retrospective cohort study. Homeopathy. 2021;110(02):086\u201393. https:\/\/doi.org\/10.1055\/s-0040-1718584.","journal-title":"Homeopathy."},{"issue":"11","key":"67_CR101","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/13543784.2020.1821645","volume":"29","author":"SA Doggrell","year":"2020","unstructured":"Doggrell SA. Remdesivir, a remedy or a ripple in severe COVID-19. Expert Opin Invest Drug. 2020;29(11):1195\u20138. https:\/\/doi.org\/10.1080\/13543784.2020.1821645.","journal-title":"Expert Opin Invest Drug"},{"issue":"03","key":"67_CR102","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1055\/s-0040-1714061","volume":"109","author":"S Prajapati","year":"2020","unstructured":"Prajapati S. Isopathic remedy prepared from convalescent plasma as a therapeutic option for COVID-19? Homeopathy. 2020;109(03):184\u20135. https:\/\/doi.org\/10.1055\/s-0040-1714061.","journal-title":"Homeopathy."},{"issue":"6518","key":"67_CR103","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, et al. Neuropilin-1 facilitates SARS-COV-2 cell entry and infectivity. Science. 2020;370(6518):856\u201360. https:\/\/doi.org\/10.1126\/science.abd2985.","journal-title":"Science."},{"issue":"5","key":"67_CR104","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1128\/mcb.18.5.2986","volume":"18","author":"R Lin","year":"1998","unstructured":"Lin R, Heylbroeck C, Pitha PM, Hiscott J. Virus-dependent phosphorylation of the irf-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol. 1998;18(5):2986\u201396. https:\/\/doi.org\/10.1128\/mcb.18.5.2986.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"67_CR105","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/sctm.20-0472","volume":"10","author":"G Lanzoni","year":"2021","unstructured":"Lanzoni G, Linetsky E, Correa D, Messinger Cayetano S, Alvarez RA, Kouroupis D, et al. Cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1\/2a, randomized controlled trial. Stem Cells Transl Med. 2021;10(5):660\u201373. https:\/\/doi.org\/10.1002\/sctm.20-0472.","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"67_CR106","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.3390\/ma14123164","volume":"14","author":"N Peyravian","year":"2021","unstructured":"Peyravian N, Malekzadeh Kebria M, Kiani J, Brouki Milan P, Mozafari M. CRISPR-associated (CAS) effectors delivery via microfluidic cell-deformation Chip. Materials. 2021;14(12):3164. https:\/\/doi.org\/10.3390\/ma14123164.","journal-title":"Materials."},{"issue":"6","key":"67_CR107","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/biom11060787","volume":"11","author":"MA Coban","year":"2021","unstructured":"Coban MA, Morrison J, Maharjan S, Hernandez Medina DH, Li W, Zhang YS, et al. Attacking COVID-19 progression using multi-drug therapy for synergetic target engagement. Biomolecules. 2021;11(6):787. https:\/\/doi.org\/10.3390\/biom11060787.","journal-title":"Biomolecules."},{"issue":"2","key":"67_CR108","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/13651501.2020.1843182","volume":"25","author":"E S\u00f6nmez G\u00fcng\u00f6r","year":"2021","unstructured":"S\u00f6nmez G\u00fcng\u00f6r E, Yal\u00e7\u0131n M, Yerebakan T\u00fczer M, Be\u015fik\u00e7i Kele\u015f D, \u00d6cek Ba\u015f T, Ergelen M, et al. Adverse drug reactions associated with concurrent acute psychiatric treatment and Covid-19 drug therapy. Int J Psychiatry Clin Pract. 2021;25(2):142\u20136. https:\/\/doi.org\/10.1080\/13651501.2020.1843182.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"Supplement_1","key":"67_CR109","doi-asserted-by":"publisher","first-page":"zvab060\u2013030","DOI":"10.1093\/eurjcn\/zvab060.030","volume":"20","author":"MA Abhyankar","year":"2021","unstructured":"Abhyankar MA, Kumar SH, Kumar BK, Swain SK, Walavalkar AM, Silki SI. Triple drug therapy to manage uncontrolled BP in hypertensive patients during Covid-19 lockdown: perspectives from India. Eur J Cardiovasc Nurs. 2021;20(Supplement_1):zvab060\u2013030. https:\/\/doi.org\/10.1093\/eurjcn\/zvab060.030.","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"2","key":"67_CR110","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10741-020-10037-x","volume":"26","author":"EA Adeghate","year":"2021","unstructured":"Adeghate EA, Eid N, Singh J. Mechanisms of COVID-19-induced heart failure: a short review. Heart Fail Rev. 2021;26(2):363\u20139. https:\/\/doi.org\/10.1007\/s10741-020-10037-x.","journal-title":"Heart Fail Rev"},{"key":"67_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104490","volume":"106","author":"K Mohamed","year":"2021","unstructured":"Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N. Computational drug discovery and repurposing for the treatment of COVID-19: a systematic review. Bioorg Chem. 2021;106:104490. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104490.","journal-title":"Bioorg Chem"},{"issue":"2","key":"67_CR112","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","volume":"21","author":"L Dai","year":"2021","unstructured":"Dai L, Gao G. Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2021;21(2):73\u201382. https:\/\/doi.org\/10.1038\/s41577-020-00480-0.","journal-title":"Nat Rev Immunol"},{"issue":"324","key":"67_CR113","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ijcard.2020.09.064","volume":"1","author":"C Godino","year":"2021","unstructured":"Godino C, Scotti A, Maugeri N, Mancini N, Fominskiy E, Margonato A, et al. Antithrombotic therapy in patients with COVID-19?-rationale and evidence. Int J Cardiol. 2021;1(324):261\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2020.09.064.","journal-title":"Int J Cardiol"},{"issue":"1","key":"67_CR114","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000508062","volume":"50","author":"D Katagiri","year":"2021","unstructured":"Katagiri D, Ishikane M, Ogawa T, Kinoshita N, Katano H, Suzuki T, et al. Continuous renal replacement therapy for a patient with severe COVID-19. Blood Purif. 2021;50(1):129\u201331. https:\/\/doi.org\/10.1159\/000508062.","journal-title":"Blood Purif"},{"issue":"9","key":"67_CR115","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2174\/1874467213666201204154239","volume":"27","author":"A Aziz","year":"2021","unstructured":"Aziz A, Asif M, Ashraf G, Yang Q, Wang S. COVID-19 impacts, diagnosis and possible therapeutic techniques: a comprehensive review. Curr Pharm Des. 2021;27(9):1170\u201384. https:\/\/doi.org\/10.2174\/1874467213666201204154239.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"67_CR116","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/ph14040336","volume":"14","author":"A Noce","year":"2021","unstructured":"Noce A, Albanese M, Marrone G, Di Lauro M, Pietroboni Zaitseva A, Palazzetti D, et al. Ultramicronized palmitoylethanolamide [um-PEA]: a new possible adjuvant treatment in COVID-19 patients. Pharmaceuticals. 2021;14(4):336. https:\/\/doi.org\/10.3390\/ph14040336.","journal-title":"Pharmaceuticals."},{"issue":"3","key":"67_CR117","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","volume":"182","author":"L Dai","year":"2020","unstructured":"Dai L, Zheng T, Xu K, Han Y, Xu L, Huang E, et al. A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS. Cell. 2020;182(3):722\u201333.e11. https:\/\/doi.org\/10.1016\/j.cell.2020.06.035.","journal-title":"Cell."},{"issue":"4","key":"67_CR118","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1086\/381535","volume":"189","author":"T Li","year":"2004","unstructured":"Li T, Qiu Z, Zhang L, Han Y, He W, Liu Z, et al. Significant changes of peripheral t lymphocyte subsets in patients with severe acute respiratory syndrome. J Infect Dis. 2004;189(4):648\u201351. https:\/\/doi.org\/10.1086\/381535.","journal-title":"J Infect Dis"},{"issue":"1","key":"67_CR119","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.sapharm.2020.04.003","volume":"17","author":"H Li","year":"2021","unstructured":"Li H, Zheng S, Liu F, Liu W, Zhao R. Fighting against COVID-19: innovative strategies for clinical pharmacists. Res Soc Adm Pharm. 2021;17(1):1813\u20138. https:\/\/doi.org\/10.1016\/j.sapharm.2020.04.003.","journal-title":"Res Soc Adm Pharm"},{"issue":"2","key":"67_CR120","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11010-020-03924-2","volume":"476","author":"P Kumar","year":"2021","unstructured":"Kumar P, Sah AK, Tripathi G, Kashyap A, Tripathi A, Rao R, et al. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19. Mol Cell Biochem. 2021;476(2):553\u201374. https:\/\/doi.org\/10.1007\/s11010-020-03924-2.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"67_CR121","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000508657","volume":"50","author":"EV Fominskiy","year":"2021","unstructured":"Fominskiy EV, Scandroglio AM, Monti G, Calabr\u00f2 MG, Landoni G, et al. Prevalence, characteristics, risk factors, and outcomes of invasively ventilated COVID-19 patients with acute kidney injury and renal replacement therapy. Blood Purif. 2021;50(1):102\u20139. https:\/\/doi.org\/10.1159\/000508657.","journal-title":"Blood Purif"},{"issue":"7","key":"67_CR122","doi-asserted-by":"publisher","first-page":"e1003660","DOI":"10.1371\/journal.pmed.1003660","volume":"18","author":"S Iwanami","year":"2021","unstructured":"Iwanami S, Ejima K, Kim KS, Noshita K, Fujita Y, Miyazaki T, et al. Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: a modeling study. PLoS Med. 2021;18(7):e1003660. https:\/\/doi.org\/10.1371\/journal.pmed.1003660.","journal-title":"PLoS Med"},{"issue":"6","key":"67_CR123","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s10875-006-9046-y","volume":"26","author":"H Shao","year":"2006","unstructured":"Shao H, Lan D, Duan Z, Liu Z, Min J, Zhang L, et al. Upregulation of mitochondrial gene expression in pbmc from convalescent sars patients. J Clin Immunol. 2006;26(6):546\u201354. https:\/\/doi.org\/10.1007\/s10875-006-9046-y.","journal-title":"J Clin Immunol"},{"key":"67_CR124","doi-asserted-by":"publisher","unstructured":"Zhou N, Yang X, Huang A, Chen Z. The potential mechanism of N-acetylcysteine in treating COVID-19. Curr Pharm Biotechnol. 2021. https:\/\/doi.org\/10.2174\/1389201021999201228212043.","DOI":"10.2174\/1389201021999201228212043"},{"issue":"7","key":"67_CR125","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/lary.29424","volume":"131","author":"C Little","year":"2021","unstructured":"Little C, Cosetti MK. A narrative review of pharmacologic treatments for COVID-19: safety considerations and ototoxicity. Laryngoscope. 2021;131(7):1626\u201332. https:\/\/doi.org\/10.1002\/lary.29424.","journal-title":"Laryngoscope"},{"key":"67_CR126","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.2147\/JIR.S306849","volume":"14","author":"KK Wong","year":"2021","unstructured":"Wong KK, Lee SW, Kua KP. N-acetylcysteine as adjuvant therapy for COVID-19\u2013a perspective on the current state of the evidence. J Inflamm Res. 2021;14:2993. https:\/\/doi.org\/10.2147\/JIR.S306849.","journal-title":"J Inflamm Res"},{"key":"67_CR127","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1056\/NEJMoa2007621","volume":"382","author":"MR Mehra","year":"2020","unstructured":"Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020;382:2582. https:\/\/doi.org\/10.1056\/NEJMoa2007621.","journal-title":"N Engl J Med"},{"issue":"3","key":"67_CR128","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/2048872620922784","volume":"9","author":"N Naksuk","year":"2020","unstructured":"Naksuk N, Lazar S, Peeraphatdit T. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol. Eur Heart J Acute Cardiovasc Care. 2020;9(3):215\u201321. https:\/\/doi.org\/10.1177\/2048872620922784.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"17","key":"67_CR129","doi-asserted-by":"publisher","first-page":"e016948","DOI":"10.1161\/JAHA.120.016948","volume":"9","author":"C Sardu","year":"2020","unstructured":"Sardu C, Maggi P, Messina V, Iuliano P, Sardu A, Iovinella V, et al. Could anti hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? Data from centers of southern Italy. J Am Heart Assoc. 2020;9(17):e016948. https:\/\/doi.org\/10.1161\/JAHA.120.016948.","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"67_CR130","doi-asserted-by":"publisher","first-page":"e016509","DOI":"10.1161\/JAHA.120.016509","volume":"9","author":"R Sommerstein","year":"2020","unstructured":"Sommerstein R, Kochen MM, Messerli FH, Gr\u00e4ni C. Coronavirus disease 2019 [COVID-19]: do angiotensin converting enzyme inhibitors\/angiotensin receptor blockers have a biphasic effect? J Am Heart Assoc. 2020;9(7):e016509. https:\/\/doi.org\/10.1161\/JAHA.120.016509.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"67_CR131","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11684-020-0800-y","volume":"14","author":"J Xu","year":"2020","unstructured":"Xu J, Huang C, Fan G, Liu Z, Shang L, Zhou F, et al. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Front Med. 2020;14(5):601\u201312. https:\/\/doi.org\/10.1007\/s11684-020-0800-y.","journal-title":"Front Med"},{"issue":"2","key":"67_CR132","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1161\/HYPERTENSIONAHA.120.15622","volume":"76","author":"F Zhou","year":"2020","unstructured":"Zhou F, Liu YM, Xie J, Li H, Lei F, Yang H, et al. Comparative impacts of ACE [angiotensin-converting enzyme] inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality. Hypertension. 2020;76(2):e15\u20137. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15622.","journal-title":"Hypertension."},{"key":"67_CR133","doi-asserted-by":"publisher","unstructured":"Liu X, Long C, Xiong Q, Chen C, Ma J, Su Y, et al. Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients with COVID19: a rapid systematic review and meta analysis. Clin Cardiol. 2020. https:\/\/doi.org\/10.1002\/clc.23421.","DOI":"10.1002\/clc.23421"},{"issue":"6","key":"67_CR134","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/ejhf.1924","volume":"22","author":"DM Bean","year":"2020","unstructured":"Bean DM, Kraljevic Z, Searle T, Bendayan R, Kevin OG, et al. Angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multisite UK acute hospital trust. Eur J Heart Fail. 2020;22(6):967\u201374. https:\/\/doi.org\/10.1002\/ejhf.1924.","journal-title":"Eur J Heart Fail"},{"key":"67_CR135","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fphar.2021.633680","volume":"12","author":"RW Malone","year":"2021","unstructured":"Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, et al. COVID-19: famotidine, histamine, mast cells, and mechanisms. Front Pharmacol. 2021;12:216. https:\/\/doi.org\/10.3389\/fphar.2021.633680.","journal-title":"Front Pharmacol"},{"key":"67_CR136","doi-asserted-by":"publisher","unstructured":"Falck-Jones S, Vangeti S, Yu M, Falck-Jones R, Cagigi A, Badolati I, et al. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity. J Clin Invest. 2021;131(6). https:\/\/doi.org\/10.1172\/JCI144734.","DOI":"10.1172\/JCI144734"},{"issue":"4","key":"67_CR137","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.mehy.2013.06.026","volume":"81","author":"CF Wenceslau","year":"2013","unstructured":"Wenceslau CF, McCarthy CG, Goulopoulou S, Szasz T, NeSmith EG, Webb RC. Mitochondrial-derived n-formyl peptides: novel links between trauma, vascular collapse and sepsis. Med Hypotheses. 2013;81(4):532\u20135. https:\/\/doi.org\/10.1016\/j.mehy.2013.06.026.","journal-title":"Med Hypotheses"},{"issue":"1-2","key":"67_CR138","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1080\/08830185.2020.1844195","volume":"40","author":"RC Borges","year":"2021","unstructured":"Borges RC, Hohmann MS, Borghi SM. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome. Int Rev Immunol. 2021;40(1-2):108\u201325. https:\/\/doi.org\/10.1080\/08830185.2020.1844195.","journal-title":"Int Rev Immunol"},{"key":"67_CR139","doi-asserted-by":"publisher","unstructured":"Kusnadi A, Ram\u00edrez-Su\u00e1stegui C, Fajardo V, Chee SJ, Meckiff BJ, Simon H, et al. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells. Sci Immunol. 2021;6(55). https:\/\/doi.org\/10.1101\/2020.07.09.194027.","DOI":"10.1101\/2020.07.09.194027"},{"issue":"1","key":"67_CR140","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12015-020-10017-6","volume":"17","author":"D Esquivel","year":"2021","unstructured":"Esquivel D, Mishra R, Soni P, Seetharaman R, Mahmood A, Srivastava A. Stem cells therapy as a possible therapeutic option in treating COVID-19 patients. Stem Cell Rev Rep. 2021;17(1):144\u201352. https:\/\/doi.org\/10.1007\/s12015-020-10017-6.","journal-title":"Stem Cell Rev Rep"},{"issue":"4","key":"67_CR141","doi-asserted-by":"publisher","first-page":"e1009448","DOI":"10.1371\/journal.ppat.1009448","volume":"17","author":"F Bozzano","year":"2021","unstructured":"Bozzano F, Dentone C, Perrone C, Di Biagio A, Fenoglio D, Parodi A, et al. Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity. PLoS Pathog. 2021;17(4):e1009448. https:\/\/doi.org\/10.1371\/journal.ppat.1009448.","journal-title":"PLoS Pathog"},{"issue":"6","key":"67_CR142","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.7150\/ijbs.59534","volume":"17","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zheng J, Islam MS, Yang Y, Hu Y, Chen X. The role of CD4+ FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment. Int J Biol Sci. 2021;17(6):1507. https:\/\/doi.org\/10.7150\/ijbs.59534.","journal-title":"Int J Biol Sci"},{"key":"67_CR143","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fimmu.2021.627548","volume":"12","author":"MA Zingaropoli","year":"2021","unstructured":"Zingaropoli MA, Nijhawan P, Carraro A, Pasculli P, Zuccal\u00e0 P, Perri V, et al. Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia. Front Immunol. 2021;12:147. https:\/\/doi.org\/10.3389\/fimmu.2021.627548.","journal-title":"Front Immunol"},{"issue":"175","key":"67_CR144","doi-asserted-by":"publisher","first-page":"20200950","DOI":"10.1098\/rsif.2020.0950","volume":"18","author":"NT Fadai","year":"2021","unstructured":"Fadai NT, Sachak-Patwa R, Byrne HM, Maini PK, Bafadhel M, Nicolau DV Jr. Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19. J R Soc Interface. 2021;18(175):20200950. https:\/\/doi.org\/10.1098\/rsif.2020.0950.","journal-title":"J R Soc Interface"},{"issue":"1","key":"67_CR145","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12015-020-10032-7","volume":"17","author":"JL Rocha","year":"2021","unstructured":"Rocha JL, de Oliveira WC, Noronha NC, Dos Santos NC, Covas DT, Pican\u00e7o-Castro V, et al. Mesenchymal stromal cells in viral infections: implications for COVID-19. Stem Cell Rev Rep. 2021;17(1):71\u201393. https:\/\/doi.org\/10.1007\/s12015-020-10032-7.","journal-title":"Stem Cell Rev Rep"},{"issue":"7285","key":"67_CR146","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature08780","volume":"464","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial damps cause inflammatory responses to injury. Nature. 2010;464(7285):104\u20137. https:\/\/doi.org\/10.1038\/nature08780.","journal-title":"Nature."},{"key":"67_CR147","doi-asserted-by":"publisher","unstructured":"Bange EM, Han NA, Wileyto P, Kim JY, Gouma S, Robinson J, et al. CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer. Res Square. 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-162289\/v1.","DOI":"10.21203\/rs.3.rs-162289\/v1"},{"key":"67_CR148","doi-asserted-by":"publisher","unstructured":"Saichi M, Ladjemi MZ, Korniotis S, Rousseau C, Hamou ZA, Massenet-Regad L, et al. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat Cell Biol. 2021;(5):538\u201351. https:\/\/doi.org\/10.1038\/s41556-021-00681-2.","DOI":"10.1038\/s41556-021-00681-2"},{"issue":"2","key":"67_CR149","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1002\/ctm2.297","volume":"11","author":"X Xu","year":"2021","unstructured":"Xu X, Jiang W, Chen L, Xu Z, Zhang Q, Zhu M, et al. Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: an exploratory clinical trial. Clin Transl Med. 2021;11(2):e297. https:\/\/doi.org\/10.1002\/ctm2.297.","journal-title":"Clin Transl Med"},{"issue":"7","key":"67_CR150","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1042\/CS20120130","volume":"123","author":"S Goulopoulou","year":"2012","unstructured":"Goulopoulou S, Matsumoto T, Bomfim GF, Webb RC. Toll-like receptor 9 activation: a novel mechanism linking placenta-derived mitochondrial DNA and vascular dysfunction in pre-eclampsia. Clin Sci. 2012;123(7):429\u201335. https:\/\/doi.org\/10.1042\/CS20120130.","journal-title":"Clin Sci"},{"issue":"3","key":"67_CR151","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41423-020-00557-9","volume":"18","author":"S Varchetta","year":"2021","unstructured":"Varchetta S, Mele D, Oliviero B, Mantovani S, Ludovisi S, Cerino A, et al. Unique immunological profile in patients with COVID-19. Cell Mol Immunol. 2021;18(3):604\u201312. https:\/\/doi.org\/10.1038\/s41423-020-00557-9.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"67_CR152","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/07853890.2020.1858234","volume":"53","author":"K Taniguchi-Ponciano","year":"2021","unstructured":"Taniguchi-Ponciano K, Vadillo E, Mayani H, Gonzalez-Bonilla CR, Torres J, Majluf A, et al. Increased expression of hypoxia-induced factor 1\u03b1 mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients. Ann Med. 2021;53(1):197\u2013207. https:\/\/doi.org\/10.1080\/07853890.2020.1858234.","journal-title":"Ann Med"},{"issue":"5","key":"67_CR153","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"E Stephenson","year":"2021","unstructured":"Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med. 2021;27(5):904\u201316. https:\/\/doi.org\/10.1038\/s41591-021-01329-2.","journal-title":"Nat Med"},{"key":"67_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107233","volume":"90","author":"LH Cavalcante-Silva","year":"2021","unstructured":"Cavalcante-Silva LH, Carvalho DC, de Almeida L\u00c9, Galv\u00e3o JG, da Silva JS, de Sales-Neto JM, et al. Neutrophils and COVID-19: the road so far. Int Immunopharmacol. 2021;90:107233. https:\/\/doi.org\/10.1016\/j.intimp.2020.107233.","journal-title":"Int Immunopharmacol"},{"key":"67_CR155","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bbrc.2020.10.079","volume":"538","author":"B Kalfaoglu","year":"2021","unstructured":"Kalfaoglu B, Almeida-Santos J, Tye CA, Satou Y, Ono M. T-cell dysregulation in COVID-19. Biochem Biophys Res Commun. 2021;538:204\u201310. https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.079.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"67_CR156","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10311-020-01091-w","volume":"19","author":"B Paital","year":"2021","unstructured":"Paital B, Agrawal PK. Air pollution by NO 2 and PM 2.5 explains COVID-19 infection severity by overexpression of angiotensin-converting enzyme 2 in respiratory cells: a review. Environ Chem Lett. 2021;19(1):25\u201342. https:\/\/doi.org\/10.1007\/s10311-020-01091-w.","journal-title":"Environ Chem Lett"},{"key":"67_CR157","doi-asserted-by":"publisher","unstructured":"Kvedaraite E, Hertwig L, Sinha I, Ponzetta A, Myrberg IH, Lourda M, et al. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity. Proc Natl Acad Sci. 2021;118(6). https:\/\/doi.org\/10.1073\/pnas.2018587118.","DOI":"10.1073\/pnas.2018587118"},{"issue":"3","key":"67_CR158","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000514202","volume":"182","author":"M Rezaei","year":"2021","unstructured":"Rezaei M, Marjani M, Mahmoudi S, Mortaz E, Mansouri D. Dynamic changes of lymphocyte subsets in the course of covid-19. Int Arch Allergy Immunol. 2021;182(3):254\u201362. https:\/\/doi.org\/10.1159\/000514202.","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"67_CR159","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/17476348.2021.1848555","volume":"15","author":"E Gorman","year":"2021","unstructured":"Gorman E, Millar J, McAuley D, O'Kane C. Mesenchymal stromal cells for acute respiratory distress syndrome [ARDS], sepsis, and COVID-19 infection: optimizing the therapeutic potential. Expert Rev Respir Med. 2021;15(3):301\u201324.","journal-title":"Expert Rev Respir Med"},{"key":"67_CR160","doi-asserted-by":"publisher","unstructured":"Dean MJ, Ochoa JB, Sanchez-Pino M, Zabaleta J, Garai J, Del Valle L, et al. Transcriptome and Functions of Granulocytic Myeloid-Derived Suppressor Cells Determine their Association with Disease Severity of COVID-19. medRxiv. 2021:03.26.21254441v1. https:\/\/doi.org\/10.1101\/2021.03.26.21254441.","DOI":"10.1101\/2021.03.26.21254441"},{"key":"67_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102598","volume":"118","author":"Y Acosta-Ampudia","year":"2021","unstructured":"Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodr\u00edguez Y, Gallo JE, Salazar-Uribe JC, et al. COVID-19 convalescent plasma composition and immunological effects in severe patients. J Autoimmun. 2021;118:102598. https:\/\/doi.org\/10.1016\/j.jaut.2021.102598.","journal-title":"J Autoimmun"},{"key":"67_CR162","doi-asserted-by":"publisher","unstructured":"Boechat JL, Chora I, Morais A, Delgado L. The immune response to SARS-COV-2 and COVID-19 immunopathology\u2013current perspectives. Pulmonology. 2021. https:\/\/doi.org\/10.1016\/j.pulmoe.2021.03.008.","DOI":"10.1016\/j.pulmoe.2021.03.008"},{"issue":"6","key":"67_CR163","doi-asserted-by":"publisher","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","volume":"34","author":"AT Tan","year":"2021","unstructured":"Tan AT, Linster M, Tan CW, Le Bert N, Chia WN, Kunasegaran K, et al. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Rep. 2021;34(6):108728. https:\/\/doi.org\/10.1016\/j.celrep.2021.108728.","journal-title":"Cell Rep"},{"issue":"11","key":"67_CR164","doi-asserted-by":"publisher","first-page":"108863","DOI":"10.1016\/j.celrep.2021.108863","volume":"34","author":"EA Thompson","year":"2021","unstructured":"Thompson EA, Cascino K, Ordonez AA, Zhou W, Vaghasia A, Hamacher-Brady A, et al. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients. Cell Rep. 2021;34(11):108863. https:\/\/doi.org\/10.1016\/j.celrep.2021.108863.","journal-title":"Cell Rep"},{"issue":"3","key":"67_CR165","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jaip.2020.12.045","volume":"9","author":"D Ferastraoaru","year":"2021","unstructured":"Ferastraoaru D, Hudes G, Jerschow E, Jariwala S, Karagic M, de Vos G, et al. Eosinophilia in asthma patients is protective against severe COVID-19 illness. J Allergy Clin Immunol Pract. 2021;9(3):1152\u201362. https:\/\/doi.org\/10.1016\/j.jaip.2020.12.045.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"67_CR166","doi-asserted-by":"publisher","unstructured":"Boulanger M, Molina E, Wang K, Kickler T, Xu Y, Garibaldi BT. Peripheral plasma cells associated with mortality benefit in severe COVID-19: a marker of disease resolution. Am J Med. 2021;0002934321001972. https:\/\/doi.org\/10.1016\/j.amjmed.2021.01.040.","DOI":"10.1016\/j.amjmed.2021.01.040"},{"issue":"9","key":"67_CR167","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.medj.2021.08.004","volume":"2","author":"V Mysore","year":"2021","unstructured":"Mysore V, Cullere X, Settles ML, Ji X, Kattan MW, Desjardins M, et al. Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens. Med. 2021;2(9):1050\u201371. https:\/\/doi.org\/10.1016\/j.medj.2021.08.004.","journal-title":"Med."},{"key":"67_CR168","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3389\/fbioe.2021.597958","volume":"9","author":"EM Melchor-Mart\u00ednez","year":"2021","unstructured":"Melchor-Mart\u00ednez EM, Torres Castillo NE, Macias-Garbett R, Lucero-Saucedo SL, Parra-Sald\u00edvar R, Sosa-Hern\u00e1ndez JE. Modern world applications for nano-bio materials: tissue engineering and COVID-19. Front Bioeng Biotechnol. 2021;9:393. https:\/\/doi.org\/10.3389\/fbioe.2021.597958.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"67_CR169","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s42247-020-00138-6","volume":"4","author":"A Aydin","year":"2021","unstructured":"Aydin A, Cebi G, Demirtas ZE, Erkus H, Kucukay A, Ok M, et al. Combating COVID-19 with tissue engineering: a review. Emergent Materials. 2021;4(1):329\u201349. https:\/\/doi.org\/10.1007\/s42247-020-00138-6.","journal-title":"Emergent Materials"},{"issue":"4","key":"67_CR170","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1039\/D0BM01616K","volume":"9","author":"A Seyfoori","year":"2021","unstructured":"Seyfoori A, Amereh M, Dabiri SM, Askari E, Walsh T, Akbari M. The role of biomaterials and three dimensional [3D] in vitro tissue models in fighting against COVID-19. Biomaterials Sci. 2021;9(4):1217\u201326. https:\/\/doi.org\/10.1039\/D0BM01616K.","journal-title":"Biomaterials Sci"},{"issue":"1","key":"67_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-84780","volume":"11","author":"S Souchelnytskyi","year":"2021","unstructured":"Souchelnytskyi S, Nera A, Souchelnytskyi N. COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response. Sci Rep. 2021;11(1):1\u20131. https:\/\/doi.org\/10.1038\/s41598-021-84780.","journal-title":"Sci Rep"},{"key":"67_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2021.113096","volume":"496","author":"A David","year":"2021","unstructured":"David A, Scott L, Jugwanth S, Gededzha M, Kahamba T, Zwane N, et al. Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response. J Immunol Methods. 2021;496:113096. https:\/\/doi.org\/10.1016\/j.jim.2021.113096.","journal-title":"J Immunol Methods"},{"issue":"9","key":"67_CR173","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3390\/jof7090720","volume":"7","author":"M Roudbary","year":"2021","unstructured":"Roudbary M, Kumar S, Kumar A, \u010cern\u00e1kov\u00e1 L, Nikoomanesh F, Rodrigues CF. Overview on the prevalence of fungal infections, immune response, and microbiome role in COVID-19 patients. J Fungi. 2021;7(9):720. https:\/\/doi.org\/10.3390\/jof7090720.","journal-title":"J Fungi"},{"key":"67_CR174","doi-asserted-by":"publisher","unstructured":"Grifoni A, Sidney J, Vita R, Peters B, Crotty S, Weiskopf D, et al. SARS-COV-2 Human T cell Epitopes: adaptive immune response against COVID-19. Cell Host Microbe. 2021;1931312821002389. https:\/\/doi.org\/10.1016\/j.chom.2021.05.010.","DOI":"10.1016\/j.chom.2021.05.010"},{"issue":"3","key":"67_CR175","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/v13030378","volume":"13","author":"A Peddapalli","year":"2021","unstructured":"Peddapalli A, Gehani M, Kalle AM, Peddapalli SR, Peter AE, Sharad S. Demystifying excess immune response in COVID-19 to reposition an orphan drug for Down-regulation of NF-\u03baB: a systematic review. Viruses. 2021;13(3):378. https:\/\/doi.org\/10.3390\/v13030378.","journal-title":"Viruses."},{"key":"67_CR176","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbrc.2021.01.073","volume":"543","author":"VA Smits","year":"2021","unstructured":"Smits VA, Hern\u00e1ndez-Carralero E, Paz-Cabrera MC, Cabrera E, Hern\u00e1ndez-Reyes Y, Hern\u00e1ndez-Fernaud JR, et al. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients. Biochem Biophys Res Commun. 2021;543:45\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2021.01.073.","journal-title":"Biochem Biophys Res Commun"},{"key":"67_CR177","doi-asserted-by":"publisher","unstructured":"Hussain A, Rafeeq H, Asif HM, Shabbir S, Bilal M, Mulla SI, et al. Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries. Int Immunopharmacol. 2021;108050. https:\/\/doi.org\/10.1016\/j.intimp.2021.108050.","DOI":"10.1016\/j.intimp.2021.108050"},{"key":"67_CR178","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fimmu.2021.631139","volume":"12","author":"CR Triggle","year":"2021","unstructured":"Triggle CR, Bansal D, Ding H, Islam MM, Farag EA, Hadi HA, et al. A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-COV-2 and COVID-19 as a basis for controlling the pandemic. Front Immunol. 2021;12:338. https:\/\/doi.org\/10.3389\/fimmu.2021.631139.","journal-title":"Front Immunol"},{"key":"67_CR179","doi-asserted-by":"publisher","first-page":"204201882110101","DOI":"10.1177\/20420188211010105","volume":"12","author":"S Salciccia","year":"2021","unstructured":"Salciccia S, Del Giudice F, Eisenberg ML, Mastroianni CM, De Berardinis E, Ricciuti GP, et al. Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection. Therapeutic Adv Endocrinol Metab. 2021;12:20420188211010105. https:\/\/doi.org\/10.1177\/20420188211010105.","journal-title":"Therapeutic Adv Endocrinol Metab"},{"key":"67_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/25785826.2020.1870305","volume":"12","author":"N Saad","year":"2021","unstructured":"Saad N, Moussa S. Immune response to COVID-19 infection: a double-edged sword. Immunol Med. 2021;12:1\u20130. https:\/\/doi.org\/10.1080\/25785826.2020.1870305.","journal-title":"Immunol Med"},{"issue":"51","key":"67_CR181","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.1016\/j.vaccine.2017.10.097","volume":"35","author":"S Kalimuddin","year":"2017","unstructured":"Kalimuddin S, Wijaya L, Chan YFZ, Wong AWL, Oh HML, Wang LF, et al. A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen. Vaccine. 2017;35(51):7127\u201332. https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.097.","journal-title":"Vaccine."},{"issue":"1","key":"67_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-021-00541-w","volume":"7","author":"S Sciacchitano","year":"2021","unstructured":"Sciacchitano S, Sacconi A, De Vitis C, Blandino G, Piaggio G, Salvati V, et al. H-Ras gene takes part to the host immune response to COVID-19. Cell Death Dis. 2021;7(1):1\u20133. https:\/\/doi.org\/10.1038\/s41420-021-00541-w.","journal-title":"Cell Death Dis"},{"key":"67_CR183","doi-asserted-by":"publisher","unstructured":"Wise J. Covid-19: Rare immune response may cause clots after AstraZeneca vaccine, say researchers. 2021;373:n954. https:\/\/doi.org\/10.1136\/bmj.n954.","DOI":"10.1136\/bmj.n954"},{"key":"67_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.cnsns.2020.105584","volume":"95","author":"AE Almocera","year":"2021","unstructured":"Almocera AE, Quiroz G, Hernandez-Vargas EA. Stability analysis in COVID-19 within-host model with immune response. Commun Nonlinear Sci Numer Simul. 2021;95:105584. https:\/\/doi.org\/10.1016\/j.cnsns.2020.105584.","journal-title":"Commun Nonlinear Sci Numer Simul"},{"key":"67_CR185","doi-asserted-by":"publisher","unstructured":"Velasco M, Gal\u00e1n MI, Casas ML, P\u00e9rez-Fern\u00e1ndez E, Mart\u00ednez-Ponce D, Gonz\u00e1lez-Pi\u00f1eiro B, et al. Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-COV-2 vaccine. medRxiv. 2021:03.08.21253065v2. https:\/\/doi.org\/10.1101\/2021.03.08.21253065.","DOI":"10.1101\/2021.03.08.21253065"},{"key":"67_CR186","doi-asserted-by":"publisher","unstructured":"Quast I, Tarlinton D. B cell memory: understanding COVID-19. Immunity. 2021;1074761321000376. https:\/\/doi.org\/10.1016\/j.immuni.2021.01.014.","DOI":"10.1016\/j.immuni.2021.01.014"},{"issue":"3","key":"67_CR187","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.chom.2016.07.008","volume":"20","author":"L Chatel-Chaix","year":"2016","unstructured":"Chatel-Chaix L, Cortese M, Romero-Brey I, Bender S, Neufeldt CJ, Fischl W, et al. Dengue virus perturbs mitochondrial morphodynamics to dampen innate immune responses. Cell Host Microbe. 2016;20(3):342\u201356. https:\/\/doi.org\/10.1016\/j.chom.2016.07.008.","journal-title":"Cell Host Microbe"},{"key":"67_CR188","doi-asserted-by":"publisher","unstructured":"Mudd PA, Remy KE. Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity? J Clin Invest. 2021;131(1). https:\/\/doi.org\/10.1172\/JCI143928.","DOI":"10.1172\/JCI143928"},{"issue":"23","key":"67_CR189","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1056\/NEJMc2103916","volume":"384","author":"N Doria-Rose","year":"2021","unstructured":"Doria-Rose N, Suthar MS, Makowski M, O\u2019Connell S, McDermott AB, Flach B, et al. Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19. N Engl J Med. 2021;384(23):2259\u201361. https:\/\/doi.org\/10.1056\/NEJMc2103916.","journal-title":"N Engl J Med"},{"key":"67_CR190","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3389\/fmicb.2021.687513","volume":"12","author":"I Soffritti","year":"2021","unstructured":"Soffritti I, D'Accolti M, Fabbri C, Passaro A, Manfredini R, Zuliani G, et al. Oral microbiome dysbiosis is associated with symptoms severity and local immune\/inflammatory response in COVID-19 patients: a cross-sectional study. Front Microbiol. 2021;12:1397. https:\/\/doi.org\/10.3389\/fmicb.2021.687513.","journal-title":"Front Microbiol"},{"key":"67_CR191","doi-asserted-by":"publisher","unstructured":"Gordon DE, Hiatt J, Bouhaddou M, Rezelj VV, Ulferts S, Braberg H, et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020;370(6521). https:\/\/doi.org\/10.1126\/science.abe9403.","DOI":"10.1126\/science.abe9403"},{"issue":"3","key":"67_CR192","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa2035002","volume":"384","author":"DM Weinreich","year":"2021","unstructured":"Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med. 2021;384(3):238\u201351. https:\/\/doi.org\/10.1056\/NEJMoa2035002.","journal-title":"N Engl J Med"},{"key":"67_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107479","volume":"94","author":"J Yang","year":"2021","unstructured":"Yang J, Wang Q, Zhang S, Li Z, Jiang W. Immune response of frontline medical workers providing medical support for Wuhan COVID-19 patients. China Int Immunopharmacol. 2021;94:107479. https:\/\/doi.org\/10.1016\/j.intimp.2021.107479.","journal-title":"China Int Immunopharmacol"},{"issue":"1","key":"67_CR194","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10238-020-00650-3","volume":"21","author":"MP da Silveira","year":"2021","unstructured":"da Silveira MP, da Silva Fagundes KK, Bizuti MR, Starck \u00c9, Rossi RC, e Silva DT. Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature. Clin Exp Med. 2021;21(1):15\u201328. https:\/\/doi.org\/10.1007\/s10238-020-00650-3.","journal-title":"Clin Exp Med"},{"key":"67_CR195","doi-asserted-by":"publisher","unstructured":"Ciccocioppo R, Gibellini D, Astori G, Bernardi M, Bozza A, Chieregato K, et al. The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia. Stem Cell Res Ther 2021;12[1]:1\u20130. https:\/\/doi.org\/10.1186\/s13287-021-02376-9.","DOI":"10.1186\/s13287-021-02376-9"},{"issue":"6","key":"67_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07284","volume":"7","author":"C Pasquier","year":"2021","unstructured":"Pasquier C, Robichon A. Computational search of hybrid human\/SARS-COV-2 dsrna reveals unique viral sequences that diverge from those of other coronavirus strains. Heliyon. 2021;7(6):e07284. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07284.","journal-title":"Heliyon."},{"issue":"1","key":"67_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02502-7","volume":"12","author":"KN da Silva","year":"2021","unstructured":"da Silva KN, Gobatto AL, Costa-Ferro ZS, Cavalcante BR, Caria AC, de Arag\u00e3o Fran\u00e7a LS, et al. Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19? Stem Cell Res Ther. 2021;12(1):1\u201324. https:\/\/doi.org\/10.1186\/s13287-021-02502-7.","journal-title":"Stem Cell Res Ther"},{"issue":"7851","key":"67_CR198","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","volume":"591","author":"C Gaebler","year":"2021","unstructured":"Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639\u201344. https:\/\/doi.org\/10.1038\/s41586-021-03207-w.","journal-title":"Nature."}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-021-00067-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-021-00067-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-021-00067-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T03:04:10Z","timestamp":1645067050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-021-00067-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":198,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1186\/s43556-021-00067-8","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"2 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A (Not applicable).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A (Not applicable).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}